KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Elevance Health (ELV) over the last 17 years, with Q1 2025 value amounting to $40.8 billion.

  • Elevance Health's Other Operating Expenses rose 1738.6% to $40.8 billion in Q1 2025 from the same period last year, while for Dec 2025 it was $40.8 billion, marking a year-over-year increase of 1671.1%. This contributed to the annual value of $201.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Elevance Health reported Other Operating Expenses of $40.8 billion as of Q1 2025, which was up 1738.6% from -$39.0 million recorded in Q3 2024.
  • In the past 5 years, Elevance Health's Other Operating Expenses ranged from a high of $40.8 billion in Q1 2025 and a low of -$39.0 million during Q3 2024
  • For the 5-year period, Elevance Health's Other Operating Expenses averaged around $27.4 billion, with its median value being $31.4 billion (2022).
  • Per our database at Business Quant, Elevance Health's Other Operating Expenses surged by 2541.12% in 2021 and then dropped by 0.29% in 2024.
  • Over the past 5 years, Elevance Health's Other Operating Expenses (Quarter) stood at $30.9 billion in 2021, then grew by 11.11% to $34.3 billion in 2022, then grew by 1.27% to $34.8 billion in 2023, then plummeted by 100.11% to -$39.0 million in 2024, then surged by 104700.0% to $40.8 billion in 2025.
  • Its Other Operating Expenses was $40.8 billion in Q1 2025, compared to -$39.0 million in Q3 2024 and $240.0 million in Q2 2024.